Results 231 to 240 of about 6,545,816 (330)

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events. [PDF]

J Immunother Cancer
Middha P, Thummalapalli R, Quandt Z, Balaratnam K, Cardenas E, Falcon CJ, Margaret Lung Group P, Gubens MA, Huntsman S, Khan K, Li M, Lovly CM, Patel D, Zhan LJ, Liu G, Aldrich MC, Schoenfeld A, Ziv E.   +17 more
europepmc   +1 more source

Prevalence of adverse events during combination therapy, interferon a-2b and ribavirine, for chronic viral hepatitis C

, 2000
Sophie Hervé, Rémi Varin, Guillaume Savoye, Ghassan Riachi, Odile Goria, Nathalie Donnadieu, R Colín   +6 more
openalex   +1 more source

Cost of prescribed NSAID‐related gastrointestinal adverse events in elderly patients [PDF]

, 2001
Elham Rahme, Lawrence Joseph, Sheldon X. Kong, Douglas J. Watson, Jacques LeLorier   +4 more
openalex   +1 more source

Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non–Small-Cell Lung Cancer

JAMA Oncology, 2017
K. Haratani, H. Hayashi, Y. Chiba, K. Kudo, K. Yonesaka, R. Kato, H. Kaneda, Y. Hasegawa, Kaoru Tanaka, M. Takeda, K. Nakagawa   +10 more
semanticscholar   +1 more source

Peri-intubation adverse events and clinical outcomes in emergency department patients: the BARCO study. [PDF]

Crit Care
Maia IWA, Besen BAMP, Silva LOJE, von Hellmann R, Hajjar LA, Sandefur BJ, Pedrollo DF, Nogueira CG, Figueiredo NMP, Miranda CH, Martins D, Baumgratz TD, Bergesch B, Costa D, Colleoni O, Zanettini J, Freitas AP, Moreira NP, Gaspar PL, Tambelli R, Costa MC, Silveira S, Correia W, de Maria RG, Filho UAV, Weber AP, da Silva Castro V, Dornelles CFD, Tabach BS, Guimarães HP, Stanzani G, Gava TF, Mullan A, Souza HP, Ranzani OT, Bellolio F, Alencar JCG, on behalf BARCO group, da Cunha VP, Marchini JF, Moura PA, Greco F, Filippo Y, Kai RY, Chimelli GTAR, Valdivia J, Junior ELF, Rischini F, Câmara VAA, Bertotto H, Borges V, Rathke J, Melo R, Maiante AA, Silva SM, de Oliveira CMR, Reis APR, de Carvalho Rufato T, Dias G, Poloni VS, Lima K, Zenly H, Motta JC, Miranda G, Freitas A, Gasperini L, Sudbrack TR, Ribeiro AP, do Carmo GHA, de Vargas Tomelero A, Konrath AL, Zanella VC, Fuhr N, Rosa DAC, Lima IL, Varela LF, Baldino I, Zimmerman A, de Carvalho JMD, Jeffrey MM.   +79 more
europepmc   +1 more source

Canadian Adverse Events Study [PDF]

, 2004
J.A. C. Delaney
core   +1 more source

Cutaneous Adverse Events Following COVID-19 Vaccination in Japan: A Questionnaire Survey. [PDF]

Cureus
Yamamura Y, Nakashima C, Kagawa N, Aoyama Y, Yamamoto A, Kawahira H, Kubota Y, Nakajima S, Nakahara T, Fuyuno Y, Tsuruta D, Matsumoto A, Matsuo R, Abe R, Yuki A, Takahashi H, Takahashi C, Imafuku S, Sato E, Fujiwara S, Yasuda M, Tada Y, Hayashi K, Katoh N, Watanabe D, Otsuka A.   +25 more
europepmc   +1 more source

Adverse events reporting of Etelcalcetide: a real-word analysis from FAERS database. [PDF]

J Pharm Policy Pract
Zhang D, Cai Y, Sun Y, Zeng P, Wang W, Wang W, Cai C.   +6 more
europepmc   +1 more source

Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting. [PDF]

BMC Ophthalmol
Zhao T, Zheng L, Feng Y, Lao M, Huang Y, Wu G.   +5 more
europepmc   +1 more source

Adverse Events Associated with Autologous and Allogenic Blood Transfusion

, 2000
Melanie S. Kennedy, R. O’Shaughnessy, Ray C. Wasielewski, Abdül Waheed, Martha Hewitt, David Krugh   +5 more
openalex   +1 more source